DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • July 23rd, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations
This Development and Supply Agreement (this “Agreement”) is made as of July 17, 2024, (the “Effective Date”) by and between Evofem Biosciences, Inc., a Delaware corporation on behalf of itself and its wholly owned subsidiaries Evofem Biosciences Operations, Inc. and Evofem, Inc. (“Licensor”), and Pharma 1 Drug Store L.L.C., a United Arab Emirates limited liability company (“Licensee”). Licensor and Licensee are sometimes referred to collectively herein as the “Parties” or individually as a “Party.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 23rd, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 12, 2024 is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and Aditxt, Inc. (the “Buyer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 23rd, 2024 • Evofem Biosciences, Inc. • Pharmaceutical preparations
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 12, 2024, is by and among Evofem Biosciences, Inc., a Delaware corporation with offices located at 7770 Regents Road, Suite 113-618, San Diego, CA 92122 (the “Company”), and the undersigned buyer (“Buyer”).
